As of 2024-12-15, the Fair Value of Rain Therapeutics Inc (RAIN) is -8.00 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.21 USD, the upside of Rain Therapeutics Inc is -760.80%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | - | 5Y Avg | |
| Net income | -21.08 | -51.39 | -75.72 | - | -49.40 | |
| YoY growth | -93.39% | -143.79% | -47.34% | - | -94.84% | |
| Market Cap (mil) | 54.67 |
| P/E | |
| Forward P/E | -0.80x |
| EPS | -1.60 |
| Avg earnings growth rate | -94.84% |
| TTM earnings | -72.25 |